膳食花青素通过罗伊氏乳杆菌调节胆汁酸-肝FXR信号缓解年龄相关肝脂肪变
在18月龄小鼠中,膳食矢车菊素-3-O-β-葡萄糖苷(Cy-3-G)显著减少肝脏甘油三酯积累并改善血清肝酶,不改变全身糖代谢、体成分或肌肉功能。机制上,Cy-3-G通过选择性促进罗伊氏乳杆菌(Limosilactobacillus reuteri)扩增,增加胆盐水解酶活性,促进FXR抑制性牛磺-β-鼠胆酸分解,激活肝脏FXR信号,从而缓解年龄相关肝脂肪变。
要点
- 膳食Cy-3-G可减轻老年小鼠肝脂肪变并改善肝酶,不影响全身糖代谢。
- 罗伊氏乳杆菌是Cy-3-G发挥保护作用的关键菌,其增加胆盐水解酶活性。
- Cy-3-G通过降低牛磺-β-鼠胆酸激活肝脏FXR信号,肝细胞FXR为必需通路。
核心结论
- Cy-3-G通过选择性促进罗伊氏乳杆菌扩增并重塑胆汁酸组成,激活肝脏FXR信号,缓解年龄相关肝脂肪变。
研究设计与样本
- 在18月龄小鼠中给予膳食Cy-3-G干预,并结合转录组分析、肝细胞特异性FXR敲除小鼠及体外实验验证机制。
- 通过粪菌移植、合成菌群培养和直接补充罗伊氏乳杆菌验证其因果作用。
主要发现
- Cy-3-G显著减少18月龄小鼠肝脏甘油三酯积累并改善血清肝酶水平,不改变全身糖代谢、体成分或肌肉功能。
- 转录组和通路分析确定肝脏FXR信号是Cy-3-G改善脂代谢的主要介导通路,肝细胞特异性FXR敲除证实该通路必需。
- 体外实验显示Cy-3-G不直接激活肝细胞FXR,提示微生物来源信号的重要性。
- Cy-3-G扩增罗伊氏乳杆菌,增加胆盐水解酶活性,促进FXR抑制性牛磺-β-鼠胆酸分解。
- 粪菌移植、合成菌群培养和直接补充罗伊氏乳杆菌均验证其降低牛磺-β-鼠胆酸并改善肝脂肪变的因果作用。
临床怎么用
- 膳食花青素可能作为靶向肠道菌群-胆汁酸-肝FXR轴的策略,用于缓解年龄相关MASLD。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Metabolic dysfunction-associated steatotic liver disease (MASLD) is increasingly prevalent in aging populations. Dietary anthocyanins have been shown to exert metabolic benefits in aging and age-associated metabolic disorders. However, its role in protecting against age-dependent hepatic steatosis and the underlying mechanisms remain poorly defined. APPROACH AND RESULTS: In 18-month-old mice, dietary cyanidin-3-O-β-glucoside (Cy-3-G) markedly reduced hepatic triglyceride accumulation and improved serum liver enzyme levels without altering systemic glucose metabolism, body composition, or muscle function. Transcriptomic and pathway analyses identified hepatic farnesoid X receptor (FXR) signaling as the primary mediator of Cy-3-G-induced improvements in lipid metabolism. Studies in hepatocyte-specific FXR knockout mice confirmed that this pathway is essential, while in vitro assays showed that Cy-3-G does not directly activate FXR in hepatocytes, underscoring the importance of microbiota-derived signals. Notably, Limosilactobacillus reuteri was identified as a key bacterium expanded by Cy-3-G, which increased bile salt hydrolase activity and promoted the breakdown of FXR-inhibitory tauro-β-MCA. Fecal microbiota transfer, synthetic community cultures, and direct L. reuteri supplementation further validated its causal role in lowering tauro-β-MCA and improving hepatic steatosis. CONCLUSIONS: Cy-3-G alleviates age-dependent hepatic steatosis by selectively promoting L. reuteri expansion and reshaping bile acid composition to activate hepatic FXR signaling. These findings identify a gut microbiota-mediated mechanism by which a dietary anthocyanin mitigates age-related MASLD.
引用
- Chen S, Wan C, Yu C, et al. Dietary anthocyanins alleviate age-dependent hepatic steatosis by expanding Limosilactobacillus reuteri and modulating gut microbiota-bile acid-hepatic FXR signaling. Hepatology. 2026. PMID: 41746339. doi:10.1097/HEP.0000000000001721
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。